On the basis of scientific breakthroughs in the past 30 years in the field of biotechnology, the number of patents has significantly increased, particularly in relation to genetic materials. Fernando Rincón looks at the Mexican situation.
Genetic material in the form of gene or partial DNA or RNA sequences plays an important role in medical research, for example, for the development of new drugs, tests and in diagnosis, monitoring and treatment of diseases as well as in agricultural and industrial fields.
In this regard, Article 16, Section II of the Industrial Property Law states:
“Inventions that are new, the result of an inventive step and susceptible of industrial application within the meaning of this Law shall be patentable, with the exception of: […] II. biological and genetic material as found in nature.”
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at email@example.com
biotechnology, gene patents, Mexico